Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|October 9, 2018
Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal EffectsJonathan E Schoenhals, Taylor R Cushman, Hampartsoum B Barsoumian, et al.
Practical Radiation Oncology|October 8, 2025
Real-World Guide for Delivering Immunotherapy With Radiation TherapyDenton J Robinson, Hampartsoum B Barsoumian, Ansel P Nalin, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2019
IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor MicroenvironmentAilin Li, Hampartsoum B Barsoumian, Jonathan E Schoenhals, et al.
Clinical Lung Cancer|December 4, 2014
Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiationCameron W Swanick, Steven H Lin, Jordan Sutton, et al.
Translational Lung Cancer Research|May 23, 2017
Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiationJonathan E Schoenhals, Steven N Seyedin, Clark Anderson, et al.
JAMA Oncology|January 6, 2018
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung CancerTodd A Pezzi, David L Schwartz, Abdallah S R Mohamed, et al.
Frontiers in Oncology|April 27, 2019
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent PembrolizumabBrooke C Bloom, Alexander Augustyn, Todd A Pezzi, et al.
Frontiers in Oncology|September 9, 2021
Pulsed Radiation Therapy to Improve Systemic Control of Metastatic CancerKewen He, Hampartsoum B Barsoumian, Duygu Sezen, et al.
Frontiers in Immunology|November 12, 2020
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic ApproachesKatherine Klein, Kewen He, Ahmed I Younes, et al.
Cancer Immunology Research|April 18, 2020
SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung CancerDawei Chen, Hampartsoum B Barsoumian, Liangpeng Yang, et al.
Pageof 15